Home - MindMaze
Overview
MindMaze is a company specializing in digital neuro-therapeutics based in Lausanne. The company develops solutions aimed at enhancing the brain's ability to recover, learn, and adapt. Its healthcare division focuses on addressing significant challenges in neurology, including stroke, Alzheimer’s disease, and Parkinson’s disease, by creating a universal platform for brain health and recovery. MindMaze offers unique digital therapeutic interventions that have received FDA clearance and CE marking, facilitating faster recovery for patients with various neurological conditions. Founded in 2012 by CEO Dr. Tej Tadi, MindMaze is recognized as the first Swiss Unicorn and has offices in Lausanne, Baltimore, London, Paris, and Mumbai.
Details
- Category
- Biotechnology Research
- Headquarters
- Lausanne
- Type
- Privately Held
- Founded
- 2012
- Specialties
- Medical devices, Neurorehabilitation, Virtual reality, Brain imaging, Neurotechnology, 3D Technology, neural prediction, brain computer interface, and engineering
- Locations
- Chemin de Roseneck 5, Lausanne, 1006, CH
Funding
Total rounds: 10
Last round: Series unknown, Mar 17, 2022
Last round amount: US$ 105.0M
Similar companies
- https://brainpatch.ai/catalog/company/neurable/815
- https://brainpatch.ai/catalog/company/synchron-inc/640
- https://brainpatch.ai/catalog/company/flow-neuroscience-393668fe/561
- https://brainpatch.ai/catalog/company/precision-neuroscience-corporation/667
- https://brainpatch.ai/catalog/company/blackrock-neurotech/609